Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plerixafor with FLAG-Ida in Relapsed/Refractory AML
NCT01435343Phase 2Completed
- Sponsor
- Fundación PETHEMA
- Start
- Jul 2012
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of plerixafor in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started Jul 2012; status: completed.
02
Drugs
plerixafor
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01435343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01435343.